4 completed. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 2 | Completed 2 |
Follow Evgen Pharma: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| SFX-01 in the Treatment and Evaluation of Metastatic Breast Cancer SFX-01, Fulvestrant, Tamoxifen - Breast Neoplasm | Phase 2 | Completed | Evgen Pharma | 60 | 2016-10-01 | 2019-07-12 |
| SFX-01 After Subarachnoid Haemorrhage SFX-01, Placebo - Subarachnoid Hemorrhage, Spontaneous | Phase 2 | Completed | Evgen Pharma | 90 | 2016-04-01 | 2020-01-18 |
| Sulforadex in Healthy Human Males MAD Sulforadex, alpha-cyclodextrin - Prostate Cancer | Phase 1 | Completed | Evgen Pharma | 18 | 2014-01-01 | 2015-02-10 |
| Sulforadex in Healthy Volunteers SAD Sulforadex, Alpha cyclodextrin - Stage, Prostate Cancer | Phase 1 | Completed | Evgen Pharma | 29 | 2012-11-01 | 2013-09-23 |
Prostatic Neoplasms (2) · Breast Neoplasms (1) · Subarachnoid Hemorrhage (1)
alpha-cyclodextrin (2) · Aromatase Inhibitors (1) · Cyclodextrins (1) · Fulvestrant (1) · Tamoxifen (1)
United Kingdom (4) · Belgium (1) · France (1) · Spain (1)
Diederik Bulters, MBChB, BSc (1) · Sacha Howell, MD PhD (1)
2014 (1)